Dr. Cypess discusses the three pillars of research: integrative physiology, noninvasive imaging, and clinical trials, emphasizing the importance of new technologies in understanding adipocyte physiology. He highlights ongoing research into medications for obesity treatment and the complex role of bile acids in metabolism.

In this episode, Dr. Aaron Cypess reflects on pivotal moments in his career, including the influence of mentors and his decision to shift towards more clinically relevant research during his endocrinology fellowship. Dr. Cypess emphasizes the importance of precision in lab work and the value of collaboration in research, while also discussing the challenges of publishing in academia.

In this episode, Dr. Aaron Cypess, a senior investigator at NIH, discusses his research on brown adipose tissue (BAT) and its implications for metabolic diseases. The conversation highlights the importance of understanding BAT's metabolic pathways and its communication with other organ systems.

Join in to hear Dr. Nilay Chakraborty introduce MicroQuant by ATCC, highlighting the portfolio's r ease of use and significant time and cost savings due to it's innovative engineering.

Listen in to hear Dr. Chakraborty discuss the development of ATCC’s ThawReady™ Assay Ready Cells, which minimize cellular injuries from cryopreservation, allowing immediate use after thawing.

: Join in to hear Dr Nilay Chakraborty talk about his team's efforts to innovate technologies for better delivery and preservation of biological materials, emphasizing the importance of cryopreservation.

Tune in, to hear Dr. Jesse Boehm discuss the convergence of advancements that are making precision medicine more effective for a larger percentage of patients.

Tune in, to hear Dr Jesse Boehm relate his inspiring journey into the world of translational research.

Tune in to hear Dr. Jesse Boehm discusses the importance of cross-institutional collaboration in cancer research, drawing parallels to NASA’s mission planning.

In a discussion about the future of One Codex, Greenfield shares upcoming changes to his organization’s business model. He also discusses the challenges of maintaining and updating their database due to the constant changes in taxonomy.

In this episode Nick Greenfield, the founder of One Codex, discusses his transition from a background in environmental studies and international relations to establishing a microbiome company.